Cahill TJ, Baddour LM, Habib G, et al. Challenges in infective Endocarditis. J Am Coll Cardiol. 2017;69:325–44.
El Kadi S, van den Buijs DMF, Meijers T, et al. Infective endocarditis in the Netherlands: current epidemiological profile and mortality : an analysis based on partial ESC EORP collected data. Neth Heart J. 2020;28:526–36.
Article PubMed PubMed Central Google Scholar
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387:882–93.
Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32.
Delgado V, Ajmone Marsan N, de Waha S, et al. ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European society of cardiology (ESC) endorsed by the European association for Cardio-thoracic surgery (EACTS) and the European association of nuclear medicine (EANM). Eur Heart J. 2023;2023:ehad193.
Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective Endocarditis of the European society of cardiology (ESC)endorsed by: European association for Cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;2015(36):3075–128.
Khawaja MT, Larry MB, Martin HT, et al. Escalating incidence of infective endocarditis in Europe in the 21st century. Open Hear. 2021;8:e1846.
Cresti A, Chiavarelli M, Scalese M, et al. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27–35.
Article PubMed PubMed Central Google Scholar
Thornhill MH, Dayer MJ, Nicholl J, et al. An alarming rise in incidence of infective endocarditis in England since 2009: why? Lancet. 2020;395:1325–7.
Wahadat AR, Tanis W, Galema TW, et al. The impact of the multidisciplinary Endocarditis team on the management of infective endocarditis. Neth Heart J. 2023;31:29–35.
Article CAS PubMed Google Scholar
Thornhill MH, Jones S, Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586–95.
Afonso BF‑F, Gabriela T‑C, Isidre V, et al. Contemporary epidemiology and outcomes in recurrent infective endocarditis. Heart. 2020;106:596.
Alexis SL, Malik AH, George I, et al. Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review. J Am Heart Assoc. 2020;9:e17347.
Article CAS PubMed PubMed Central Google Scholar
Calderón-Parra J, Kestler M, Ramos-Martínez A, et al. Clinical factors associated with reinfection versus relapse in infective Endocarditis: prospective cohort study. J Clin Med. 2021;10(4).
Østergaard L, Valeur N, Wang A, et al. Incidence of infective endocarditis in patients considered at moderate risk. Eur Heart J. 2019;40:1355–61.
Patel S, Rizvi Ssa CJH, et al. Management and outcomes of left ventricular assist device-associated endocarditis: a systematic review. Ann Cardiothorac Surg. 2019;8:600–9.
Article PubMed PubMed Central Google Scholar
Salem M, Friedrich C, Saad M, et al. Active Infective Native and Prosthetic Valve Endocarditis: Short- and Long-Term Outcomes of Patients after Surgical Treatment. J Clin Med. 2021;10(9).
Williams ML, Doyle MP, McNamara N, Tardo D, Mathew M, Robinson B. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Ther Adv Cardiovasc Dis. 2021;15. 17539447211002687.
Fowler VG Jr, Durack DT, Selton-Suty C, et al. The 2023 duke-international society for cardiovascular infectious diseases criteria for infective Endocarditis: updating the modified duke criteria. Clin Infect Dis. 2023;77:518–26.
Article PubMed PubMed Central Google Scholar
Jain V, Wang TKM, Bansal A, et al. Diagnostic performance of cardiac computed tomography versus transesophageal echocardiography in infective endocarditis: A contemporary comparative meta-analysis. J Cardiovasc Comput Tomogr. 2021;15:313–21.
Chakraborty T, Scharf E, DeSimone D, et al. Variable significance of brain MRI findings in infective Endocarditis and its effect on surgical decisions. Mayo Clin Proc. 2019;94:1024–32.
de Camargo RA, Bitencourt SM, Meneghetti JC, et al. The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Left-sided Endocarditis: Native vs Prosthetic Valves Endocarditis. Clin Infect Dis. 2020;70:583–94.
Oliveira M, Guittet L, Hamon M, Hamon M. Comparative value of cardiac CT and Transesophageal Echocardiography in infective Endocarditis: a systematic review and meta-analysis. Radiol Cardiothorac Imaging. 2020;2:e190189.
Article PubMed PubMed Central Google Scholar
Wang TKM, Sánchez-Nadales A, Igbinomwanhia E, Cremer P, et al. Diagnosis of infective Endocarditis by subtype using (18)F-Fluorodeoxyglucose positron emission Tomography/computed Tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging. 2020;13:e10600.
Iversen K, Ihlemann N, Gill SU, et al. Partial oral versus intravenous antibiotic treatment of Endocarditis. N Engl J Med. 2018;380:415–24.
Østergaard L, Oestergaard LB, Lauridsen TK, et al. Long-term causes of death in patients with infective endocarditis who undergo medical therapy only or surgical treatment: a nationwide population-based study. Eur J Cardiothorac Surg. 2018;54:860–6.
Suzuki M, Takanashi S, Ohshima Y, et al. Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes. Int J Cardiol. 2017;227:222–4.
van der Velde ET, Vriend JWJ, Mannens MMAM, et al. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20:549–57.
Houterman S, van Dullemen A, Versteegh M, et al. Data quality and auditing within the Netherlands Heart Registration: using the PCI registry as an example. Neth Heart J. 2023;31:334–9.
Article CAS PubMed PubMed Central Google Scholar
Timmermans MJC, Houterman S, Daeter ED, et al. Using real-world data to monitor and improve quality of care in coronary artery disease: results from the Netherlands heart registration. Neth Heart J. 2022;30:546–56.
Article PubMed PubMed Central Google Scholar
van der Vaart TWBA, Deckers JW, Natour EH, Verkaik NJ, van der Meer JTM. SWAB guidelines for the antimicrobial treatment of infective endocarditis. 2019.
Statistiek CBvd. Ziekenhuisopnamen en -patiënten; diagnose-indeling ICD-10 (3-teken niveau). 2023.
Régis CA‑O, Thy M, Mahida B, et al. Absence of infective endocarditis relapse when end-of-treatment fluorodeoxyglucose positron emission tomography/computed tomography is negative. Eur Heart J Cardiovasc Imaging. 2023;24:1480–8.
Vallejo Camazon NA‑O, Mateu L, Cediel G, et al. Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis. Cardiol J. 2021;28:566–78.
Pries-Heje MM, Wiingaard C, Ihlemann N, et al. Five-year outcomes of the partial oral treatment of Endocarditis (POET) trial. N Engl J Med. 2022;386:601–2.
Anderson BR, Gotlieb EA‑O, Hill K, et al. Registry-based trials: a potential model for cost savings? Cardiol Young. 2020;30:807–17.
Article PubMed PubMed Central Google Scholar
Doherty DA, Tong SYC, Reilly JA‑O, et al. Registry randomised trials: a methodological perspective. BMJ Open. 2023;13:e68057.
Comments (0)